High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myelomaBruno Paiva, Jesús F. San Miguel, Joan Bladé et al.|Blood|2011Cited by 304
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer SurvivalJuan José Lahuerta, Jesús F. San Miguel, María‐Victoria Mateos et al.|Journal of Clinical Oncology|2008Cited by 282
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myelomaLaura Rosiñol, Joan Bladé, Josè Antonio Pérez-Simón et al.|Blood|2008Cited by 264
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myelomaLaura Rosiñol, Joan Bladé, Albert Oriol et al.|Blood|2019Cited by 218
Long-term prognostic significance of response in multiple myeloma after stem cell transplantationJoaquín Martínez‐López, Joan Bladé, María‐Victoria Mateos et al.|Blood|2011Cited by 210